Innovating Works

ACELLERA LABS

Activa
CompBioMed2: A Centre of Excellence in Computational Biomedicine UNIVERSITY COLLEGE LONDON tramitó un H2020: H2020-INFRAEDI-2018-2020 CompBioMed2 is a proposal for the second phase of the Computational Biomedicine Centre of Excellence (CoE), CompBioMed, an outward facing Co...
2019-05-13 - 2024-03-31 | Financiado
Cloud-HTMD: A CLOUD APPLICATION PLATFORM FOR RATIONAL DRUG DISCOVERY USING HIGH THROUGHPUT MOLECULAR DYNAMICS ACELLERA LABS tramitó un H2020: H2020-INNOSUP-2016-2017 Since 10 years, Acellera is at the forefront in the development of Molecular Dynamics (MD) applications for drug discovery, and is committed...
2017-02-27 - 2018-08-31 | Financiado
CompBioMed: A Centre of Excellence in Computational Biomedicine UNIVERSITY COLLEGE LONDON tramitó un H2020: H2020-EINFRA-2014-2015 This Centre of Excellence will advance the role of computationally based modelling and simulation within biomedicine. Three related user com...
2016-06-03 - 2019-09-30 | Financiado
HTMD: Feasibility assessment of a cloud application platform for rational drug design using high throughpu... ACELLERA LABS tramitó un H2020: H2020-SMEInst-2014-2015 The pharmaceutical industry’s increasing spending on R&D is not translating into new and better drugs at the pace required to maintain compe...
2015-05-28 - 2015-11-30 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.